Pfizer CEO Albert Bourla, with four Covid vaccine doses, has gone into isolation after testing positive for the virus.
“I would like to let you know that I have tested positive for COVID-19,” the CEO tweeted earlier today.
“I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms. I am isolating and have started a course of Paxlovid.”
I would like to let you know that I have tested positive for #COVID19. I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms. I am isolating and have started a course of Paxlovid.
— Albert Bourla (@AlbertBourla) August 15, 2022
Paxlovid is an oral medicine taken in tablet form, which is recommended by both the HSE and the European Medicines Agency (EMA). It is made by Pfizer, and aims to reduce the risk of serious illness or death of Covid-19. In Ireland it can be prescribed by a doctor.
“We have come so far in our efforts to battle this disease that I am confident I will have a speedy recovery,” tweeted Bourla.
“I am incredibly grateful for the tireless efforts of my Pfizer colleagues who worked to make vaccines and treatments available for me and people around the world,” he said, adding that Paxlovid is not fully approved in the US, but is authorised for emergency use by the FDA.
Paxlovid is not approved, but is authorized for emergency use by the FDA to treat mild-to-moderate COVID-19 in high-risk patients 12+, weighing at least 40 kg, with positive results of SARS-CoV-2 viral testing. See safety info: https://t.co/XqokFVKBC7.
— Albert Bourla (@AlbertBourla) August 15, 2022